571 related articles for article (PubMed ID: 28716257)
1. Associations between white matter hyperintensities and cognitive decline over three years in non-dementia older adults with memory complaints.
Moon SY; de Souto Barreto P; Chupin M; Mangin JF; Bouyahia A; Fillon L; Andrieu S; Vellas B;
J Neurol Sci; 2017 Aug; 379():266-270. PubMed ID: 28716257
[TBL] [Abstract][Full Text] [Related]
2. APOE4 and Confluent White Matter Hyperintensities Have a Synergistic Effect on Episodic Memory Impairment in Prodromal Dementia.
Kumar D; Yatawara C; Wang B; Wong B; Tan YJ; Zailan FZ; Ng KP; Kandiah N
J Alzheimers Dis; 2022; 87(3):1103-1114. PubMed ID: 35431245
[TBL] [Abstract][Full Text] [Related]
3. Association of Subjective Memory Complaints With White Matter Hyperintensities and Cognitive Decline Among Older Adults in Chicago, Illinois.
Dhana A; DeCarli C; Dhana K; Desai P; Krueger K; Evans DA; Rajan KB
JAMA Netw Open; 2022 Apr; 5(4):e227512. PubMed ID: 35426922
[TBL] [Abstract][Full Text] [Related]
4. Depression Plays a Moderating Role in the Cognitive Decline Associated With Changes of Brain White Matter Hyperintensities.
Park JH; Lee SB; Lee JJ; Yoon JC; Han JW; Kim TH; Jeong HG; Newhouse PA; Taylor WD; Kim JH; Woo JI; Kim KW
J Clin Psychiatry; 2018 Sep; 79(5):. PubMed ID: 30192448
[TBL] [Abstract][Full Text] [Related]
5. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.
Arvanitakis Z; Fleischman DA; Arfanakis K; Leurgans SE; Barnes LL; Bennett DA
Brain Struct Funct; 2016 May; 221(4):2135-46. PubMed ID: 25833685
[TBL] [Abstract][Full Text] [Related]
6. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
[TBL] [Abstract][Full Text] [Related]
7. Prospective associations between white matter hyperintensities and lower extremity function.
Moon SY; de Souto Barreto P; Rolland Y; Chupin M; Bouyahia A; Fillon L; Mangin JF; Andrieu S; Cesari M; Vellas B;
Neurology; 2018 Apr; 90(15):e1291-e1297. PubMed ID: 29523640
[TBL] [Abstract][Full Text] [Related]
8. White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults.
Jung Y; Viviano RP; van Rooden S; van der Grond J; Rombouts SARB; Damoiseaux JS
J Alzheimers Dis; 2021; 84(3):1337-1350. PubMed ID: 34657884
[TBL] [Abstract][Full Text] [Related]
9. White Matter Hyperintensities and Hippocampal Atrophy in Relation to Cognition: The 90+ Study.
Legdeur N; Visser PJ; Woodworth DC; Muller M; Fletcher E; Maillard P; Scheltens P; DeCarli C; Kawas CH; Corrada MM
J Am Geriatr Soc; 2019 Sep; 67(9):1827-1834. PubMed ID: 31169919
[TBL] [Abstract][Full Text] [Related]
10. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
11. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
12.
Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
[TBL] [Abstract][Full Text] [Related]
13. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
14. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
Low A; Ng KP; Chander RJ; Wong B; Kandiah N
J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
[TBL] [Abstract][Full Text] [Related]
16. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA
J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057
[TBL] [Abstract][Full Text] [Related]
17. Tract-defined regional white matter hyperintensities and memory.
Rizvi B; Lao PJ; Colón J; Hale C; Igwe KC; Narkhede A; Budge M; Manly JJ; Schupf N; Brickman AM
Neuroimage Clin; 2020; 25():102143. PubMed ID: 31887716
[TBL] [Abstract][Full Text] [Related]
18. Mental speed is associated with the shape irregularity of white matter MRI hyperintensity load.
Lange C; Suppa P; Mäurer A; Ritter K; Pietrzyk U; Steinhagen-Thiessen E; Fiebach JB; Spies L; Buchert R
Brain Imaging Behav; 2017 Dec; 11(6):1720-1730. PubMed ID: 27796731
[TBL] [Abstract][Full Text] [Related]
19. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
[TBL] [Abstract][Full Text] [Related]
20. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
